LifeStance director Burdick sells 75,000 shares

Q: What LFST options did Kenneth A. Burdick exercise?

He exercised options for 75,000 common shares on November 10, 2026, at $7.61 per share; he acquired those 75,000 shares and sold 75,000 common shares that day at a weighted average price of $14.60 per share.

Q: How many LFST shares does Burdick Family LLC hold?

A position entry dated November 9, 2026, lists 46,511 common shares held indirectly through Burdick Family LLC.

Available on EDGAR 11/12/2026 - 05:00 PM EST Accepted by SEC EDGAR 11/12/2026 - 05:00 PM EST

Filing Impact

(Neutral)

Filing Sentiment

(Negative)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

Rhea-AI Filing Summary

LifeStance Health Group, Inc. director Kenneth A. Burdick exercised options for 75,000 shares on November 10, 2026, at $7.61 per share, acquired the shares, and sold 75,000 common shares that day at a weighted average price of $14.60 (multiple sales ranged from $14.60 to $14.615). He also sold 66,589 shares on November 9 at a weighted average price of $14.41 (range $14.410 to $14.440). His reported option position following the exercise was 3,059,846 shares. The transactions were not reported as made under a Rule 10b5-1 plan.

Insider Trade Summary

Exercise and sale activity reported; no spread calculated

Exercise and Sale 4 txns

Insider Burdick Kenneth A

Role Director

Sold 141,589 shs ($2.05M)

Approx. gross sale proceeds $2.05M

Approx. exercise cost $571K

Type	Security	Shares	Price	Value
Exercise	Stock Option (right to buy) ^F3	75,000	$0.00	$0.00
Exercise	Common Stock	75,000	$7.61	$571K
Sale	Common Stock ^F2	75,000	$14.60	$1.09M
Sale	Common Stock ^F1	66,589	$14.41	$960K
Holding	Common Stock	--	--	--

Holdings After Transaction: Stock Option (right to buy) — 3,059,846 options (Direct); Common Stock — 2,904,221 shares (Direct); Common Stock — 46,511 shares (Indirect, By Burdick Family LLC)

Footnotes (3)

F1. The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $14.410 to $14.440 inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
F2. The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $14.60 to $14.615 inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
F3. Includes an option to purchase 3,134,846 shares of the Issuer's common stock, subject to time-based vesting (the "Time-Vesting Option"). The Time-Vesting Option vested as to 25% on each of the first four anniversaries of the vesting commencement date, September 7, 2022.

Key Figures

Shares sold: 66,589 shares Weighted average sale price: $14.41 per share Options exercised: 75,000 shares +5 more

8 metrics

Shares sold 66,589 shares November 9, 2026

Weighted average sale price $14.41 per share November 9, 2026; sales ranged from $14.410 to $14.440

Options exercised 75,000 shares November 10, 2026

Option exercise price $7.61 per share Options exercised November 10, 2026

Shares sold 75,000 shares November 10, 2026

Weighted average sale price $14.60 per share November 10, 2026; sales ranged from $14.60 to $14.615

Option shares following exercise 3,059,846 shares Reported following the November 10, 2026 exercise

Indirect common-stock holding 46,511 shares Held through Burdick Family LLC; position entry dated November 9, 2026

Key Terms

weighted average price, time-based vesting, Time-Vesting Option

3 terms

weighted average price financial

"The price reported is a weighted average price"

Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.

time-based vesting technical

"subject to time-based vesting"

Time-based vesting is a schedule that gives employees or contractors ownership of granted stock or options gradually as they remain with a company, like unlocking rewards in a loyalty program the longer you stick around. For investors, it matters because it affects future share supply, management incentives and staff retention — all of which can influence company performance and dilution of existing shareholders.

Time-Vesting Option technical

"the “Time-Vesting Option”"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many LFST shares did Kenneth A. Burdick sell and at what prices?

Kenneth A. Burdick reported selling 66,589 shares on November 9, 2026, at a weighted average price of $14.41 per share, and 75,000 shares on November 10 at a weighted average price of $14.60 per share. The reported sale ranges were $14.410 to $14.440 and $14.60 to $14.615, respectively.

What LFST options did Kenneth A. Burdick exercise?

He exercised options for 75,000 common shares on November 10, 2026, at $7.61 per share; he acquired those 75,000 shares and sold 75,000 common shares that day at a weighted average price of $14.60 per share.

How many LFST shares does Burdick Family LLC hold?

A position entry dated November 9, 2026, lists 46,511 common shares held indirectly through Burdick Family LLC.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Burdick Kenneth A

(Last)

(First)

(Middle)

C/O LIFESTANCE HEALTH GROUP, INC.

4800 N. SCOTTSDALE ROAD, SUITE 2500

(Street)

SCOTTSDALE

ARIZONA

85251

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
LifeStance Health Group, Inc. [ LFST ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
11/09/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	11/09/2026		S		66,589⁽¹⁾	D	$14.41	2,904,221	D
Common Stock	11/10/2026		M		75,000	A	$7.61	2,979,221	D
Common Stock	11/10/2026		S		75,000⁽²⁾	D	$14.6	2,904,221	D
Common Stock								46,511	I	By Burdick Family LLC

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Stock Option (right to buy)	$7.61	11/10/2026		M		75,000		⁽³⁾	09/07/2032	Common Stock	75,000	$0.00	3,059,846	D

Explanation of Responses:

1. The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $14.410 to $14.440 inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

2. The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $14.60 to $14.615 inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

3. Includes an option to purchase 3,134,846 shares of the Issuer's common stock, subject to time-based vesting (the "Time-Vesting Option"). The Time-Vesting Option vested as to 25% on each of the first four anniversaries of the vesting commencement date, September 7, 2022.

	By: /s/ Ryan Pardo, Attorney-in-Fact	11/12/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR